125 related articles for article (PubMed ID: 36907324)
1. Low dose Taxol ameliorated renal fibrosis in mice with diabetic kidney disease by downregulation of HIPK2.
Xia Y; Jiang H; Chen J; Xu F; Zhang G; Zhang D
Life Sci; 2023 May; 320():121540. PubMed ID: 36907324
[TBL] [Abstract][Full Text] [Related]
2. EGFR drives the progression of AKI to CKD through HIPK2 overexpression.
Xu L; Li X; Zhang F; Wu L; Dong Z; Zhang D
Theranostics; 2019; 9(9):2712-2726. PubMed ID: 31131063
[TBL] [Abstract][Full Text] [Related]
3. A Novel Inhibitor of Homeodomain Interacting Protein Kinase 2 Mitigates Kidney Fibrosis through Inhibition of the TGF-
Liu R; Das B; Xiao W; Li Z; Li H; Lee K; He JC
J Am Soc Nephrol; 2017 Jul; 28(7):2133-2143. PubMed ID: 28220029
[TBL] [Abstract][Full Text] [Related]
4. A systems approach identifies HIPK2 as a key regulator of kidney fibrosis.
Jin Y; Ratnam K; Chuang PY; Fan Y; Zhong Y; Dai Y; Mazloom AR; Chen EY; D'Agati V; Xiong H; Ross MJ; Chen N; Ma'ayan A; He JC
Nat Med; 2012 Mar; 18(4):580-8. PubMed ID: 22406746
[TBL] [Abstract][Full Text] [Related]
5. p53/microRNA-214/ULK1 axis impairs renal tubular autophagy in diabetic kidney disease.
Ma Z; Li L; Livingston MJ; Zhang D; Mi Q; Zhang M; Ding HF; Huo Y; Mei C; Dong Z
J Clin Invest; 2020 Sep; 130(9):5011-5026. PubMed ID: 32804155
[TBL] [Abstract][Full Text] [Related]
6. Tubular HIPK2 is a key contributor to renal fibrosis.
Xiao W; E J; Bao L; Fan Y; Jin Y; Wang A; Bauman D; Li Z; Zheng YL; Liu R; Lee K; He JC
JCI Insight; 2020 Sep; 5(17):. PubMed ID: 32701510
[TBL] [Abstract][Full Text] [Related]
7. Targeting mammalian serine/threonine-protein kinase 4 through Yes-associated protein/TEA domain transcription factor-mediated epithelial-mesenchymal transition ameliorates diabetic nephropathy orchestrated renal fibrosis.
Yang T; Heng C; Zhou Y; Hu Y; Chen S; Wang H; Yang H; Jiang Z; Qian S; Wang Y; Wang J; Zhu X; Du L; Yin X; Lu Q
Metabolism; 2020 Jul; 108():154258. PubMed ID: 32376130
[TBL] [Abstract][Full Text] [Related]
8. Astragaloside IV Alleviates Renal Tubular Epithelial-Mesenchymal Transition via CX3CL1-RAF/MEK/ERK Signaling Pathway in Diabetic Kidney Disease.
Hu Y; Tang W; Liu W; Hu Z; Pan C
Drug Des Devel Ther; 2022; 16():1605-1620. PubMed ID: 35669284
[TBL] [Abstract][Full Text] [Related]
9. ASH2L Aggravates Fibrosis and Inflammation through HIPK2 in High Glucose-Induced Glomerular Mesangial Cells.
Zhong W; Hong C; Dong Y; Li Y; Xiao C; Liu X
Genes (Basel); 2022 Nov; 13(12):. PubMed ID: 36553510
[TBL] [Abstract][Full Text] [Related]
10. MDM2 controls NRF2 antioxidant activity in prevention of diabetic kidney disease.
Guo W; Tian D; Jia Y; Huang W; Jiang M; Wang J; Sun W; Wu H
Biochim Biophys Acta Mol Cell Res; 2018 Aug; 1865(8):1034-1045. PubMed ID: 29704532
[TBL] [Abstract][Full Text] [Related]
11. The antihelmenthic phosphate niclosamide impedes renal fibrosis by inhibiting homeodomain-interacting protein kinase 2 expression.
Chang X; Zhen X; Liu J; Ren X; Hu Z; Zhou Z; Zhu F; Ding K; Nie J
Kidney Int; 2017 Sep; 92(3):612-624. PubMed ID: 28318631
[TBL] [Abstract][Full Text] [Related]
12. Baicalin ameliorates renal fibrosis by upregulating CPT1α-mediated fatty acid oxidation in diabetic kidney disease.
Hu H; Li W; Hao Y; Peng Z; Zou Z; Liang W
Phytomedicine; 2024 Jan; 122():155162. PubMed ID: 37922789
[TBL] [Abstract][Full Text] [Related]
13. Counteracting MDM2-induced HIPK2 downregulation restores HIPK2/p53 apoptotic signaling in cancer cells.
Nardinocchi L; Puca R; Givol D; D'Orazi G
FEBS Lett; 2010 Oct; 584(19):4253-8. PubMed ID: 20849851
[TBL] [Abstract][Full Text] [Related]
14. Low-dose paclitaxel ameliorates fibrosis in the remnant kidney model by down-regulating miR-192.
Sun L; Zhang D; Liu F; Xiang X; Ling G; Xiao L; Liu Y; Zhu X; Zhan M; Yang Y; Kondeti VK; Kanwar YS
J Pathol; 2011 Nov; 225(3):364-77. PubMed ID: 21984124
[TBL] [Abstract][Full Text] [Related]
15. Targeting hypoxia in cancer cells by restoring homeodomain interacting protein-kinase 2 and p53 activity and suppressing HIF-1alpha.
Nardinocchi L; Puca R; Sacchi A; Rechavi G; Givol D; D'Orazi G
PLoS One; 2009 Aug; 4(8):e6819. PubMed ID: 19714248
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of the processing of miR-25 by HIPK2-Phosphorylated-MeCP2 induces NOX4 in early diabetic nephropathy.
Oh HJ; Kato M; Deshpande S; Zhang E; Das S; Lanting L; Wang M; Natarajan R
Sci Rep; 2016 Dec; 6():38789. PubMed ID: 27941951
[TBL] [Abstract][Full Text] [Related]
17. Loss of tumour suppressor PTEN expression in renal injury initiates SMAD3- and p53-dependent fibrotic responses.
Samarakoon R; Helo S; Dobberfuhl AD; Khakoo NS; Falke L; Overstreet JM; Goldschmeding R; Higgins PJ
J Pathol; 2015 Aug; 236(4):421-32. PubMed ID: 25810340
[TBL] [Abstract][Full Text] [Related]
18. Decreased secretion and profibrotic activity of tubular exosomes in diabetic kidney disease.
Wen J; Ma Z; Livingston MJ; Zhang W; Yuan Y; Guo C; Liu Y; Fu P; Dong Z
Am J Physiol Renal Physiol; 2020 Oct; 319(4):F664-F673. PubMed ID: 32715764
[TBL] [Abstract][Full Text] [Related]
19. p53 induces miR199a-3p to suppress SOCS7 for STAT3 activation and renal fibrosis in UUO.
Yang R; Xu X; Li H; Chen J; Xiang X; Dong Z; Zhang D
Sci Rep; 2017 Feb; 7():43409. PubMed ID: 28240316
[TBL] [Abstract][Full Text] [Related]
20. The Histone Demethylase Inhibitor GSK-J4 Is a Therapeutic Target for the Kidney Fibrosis of Diabetic Kidney Disease via DKK1 Modulation.
Hung PH; Hsu YC; Chen TH; Ho C; Lin CL
Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012674
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
